Pfizer logo — Prescription medicines, vaccines and consumer products

Pfizer

Prescription medicines, vaccines and consumer products

Founded 1849 United States New York, United States 110192 employees IPO Total: $39.21B Biotechnology, Health Care +2

General Information

Company Name Pfizer
Founded Year 1849
Location United States New York, United States
Founders / Decision Makers
Team member
Employees 110192
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage IPO
Business Model B2B, B2C, D2C
Revenue Model Product Sales, Licensing

BounceWatch is an independent company data service, not affiliated with Pfizer. To contact Pfizer, visit pfizer.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pfizer compare?

A PDF of Pfizer and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pfizer soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

AI Insight

Bounce Watch AI
1 month ago

Pfizer has recently engaged in substantial financial activities, securing over €3.30B in post-IPO debt and $1.00B in post-IPO equity from investors including Starboard Value. This significant capital raise, alongside active recruitment for 41 positions, indicates a strategic focus on bolstering its financial position and optimizing its operational capacity. These developments suggest a dynamic period of resource allocation and potential strategic realignment within the pharmaceutical giant.

Signal Types
Funding Hiring
Strategic Labels
Post-IPO Capitalization Workforce Optimization Shareholder Engagement
Next Move: Investment
·
Impact: 8/10
·
Ideal For: Public Equity/Debt Investors – Mature Pharma

About Pfizer

Pfizer, a cornerstone of the global pharmaceutical landscape, has been at the forefront of scientific innovation for over 175 years. The company’s slogan, “Prescription medicines, vaccines and consumer products,” encapsulates its commitment to advancing health care solutions across various domains, including Biotechnology, Health Care, Manufacturing, and Pharmaceutical.

Founded in 1849, and headquartered in the United States, Pfizer continues to push boundaries with its expansive portfolio of medicines and vaccines. The organization underscores a forward-looking vision, as illustrated by its motto, “Let’s outdo yesterday.”

In a recent substantial endeavor, Pfizer secured a €3.30 billion investment through a Post IPO Debt financing round on May 1, 2025. This influx of capital aims to fuel continued innovation and reinforce the company’s strategic capabilities within the fast-evolving pharmaceutical sector.

Business keywords: Pharmaceuticals, Scientific Innovation, Drug Manufacturing, Vaccine Development, Consumer Health Products, Acquisitions Strategy, Medicinal Tablets, Listerine, Chiclets, Parke-Davis, Wilkinson Sword, Healthcare Services, Affordable Medicines, Global Health Resources

Services & Products

Pharmaceutical Research
Drug Development
Clinical Trials Management
Vaccine Production
Patient Assistance Programs
Healthcare Professional Support

Target Customers

Patients Healthcare Professionals Distributors Investors Healthcare Organizations Grant Seekers

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt €3.30B -
01 May 2025
Post-IPO Equity $1.00B 1
Starboard Value
01 Oct 2024
Post-IPO Debt $31.00B -
01 May 2023
Grant $2.00B 1
HHS Administration for Strategic Preparedness and Response
01 Dec 2020
Grant $1.90B -
01 Jul 2020
Grant $5.00M -
01 May 2018
IPO Undisclosed -
01 Mar 1983

Pfizer Alternatives & Competitors

View All Alternatives
Pfizer vs

We’re here to champion long-term health. Get updates on innovation and inspiring stories 💙

IPO
62491 employees
Biotechnology, Pharmaceutical
Pfizer vs

Identifying, developing and commercializing meaningful products that address unmet medical needs

IPO
3640 employees
Biotechnology, Health Care
Pfizer vs

A global biotechnology company dedicated to developing revolutionary therapies with real impact

IPO
57 employees
Biotechnology, Health Care

FAQ About Pfizer

Prescription medicines, vaccines and consumer products
Pfizer was founded in 1849.
Pfizer is headquartered in New York, United States.
Pfizer operates in Biotechnology, Health Care, Manufacturing and Pharmaceutical. Its work centres on Pharmaceuticals, Scientific Innovation, Drug Manufacturing and Vaccine Development. Its customers include Patients, Healthcare Professionals and Distributors.
Pfizer has a B2B, B2C and D2C business model. Its revenue comes from Product Sales and Licensing.
Pfizer has approximately 110192 employees.
Pfizer has completed 7 funding rounds, raising a total of $39.21B. The latest funding stage is IPO.
Pfizer offers: Pharmaceutical Research, Drug Development, Clinical Trials Management, Vaccine Production, Patient Assistance Programs, Healthcare Professional Support.
Top alternatives and competitors to Pfizer include Novo Nordisk, Jazz Pharmaceuticals, Seagen, TARIS, Biogen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pfizer and Novo Nordisk are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pfizer, https://bouncewatch.com/company/pfizer, updated 2 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes